Literature DB >> 22585718

Molecular characterization of hepatitis E virus in patients with acute hepatitis in Venezuela.

Cristina Gutiérrez García1, Doneyla Sánchez, Maria Caridad Montalvo Villalba, Flor Helene Pujol, Licel de Los Ángeles Rodríguez Lay, Belquis Pinto, Elsa Patricia Chacón, Maria Guadalupe Guzmán.   

Abstract

Hepatitis E virus (HEV) causes a common infection in developing countries. HEV infection occurs as outbreaks, as sporadic clinical cases and as large epidemics in endemic areas. The objective of this study was to determine the presence of HEV infection in patients with clinical suspicion of hepatitis A virus (HAV) infection, referred to the Instituto Nacional de Higiene "Rafael Rangel" in Venezuela. Seventy-four sera were tested for anti-HAV and anti-HEV IgM antibodies. HEV-RNA was amplified from anti-HEV IgM positive sera using nested reverse transcription polymerase chain reaction for ORF1 (RNA dependent RNA polymerase region) and the amplicons sequenced for phylogenetic analysis. The frequency of anti-HEV IgM was 22/74 (30%) in the samples tested. Dual infection with HAV and HEV was found in 31% (12/39) of anti-HAV IgM positive patients. Viremia was detected in 3/22 (14%) of sera positive for anti-HEV IgM. Two HEV strains were classified as genotype 1 and one as genotype 3, which were closely related to Yam 67 (north of India) and US1 isolates from the USA, respectively. These findings suggest that HEV is an important cause of acute viral hepatitis in Venezuela as a single infection or co-infection with HAV, with high morbidity in children and young adults suggesting that this infection is endemic in Venezuela.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585718     DOI: 10.1002/jmv.23277

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 2.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

3.  Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis.

Authors:  Nathalie Verónica Fernández Villalobos; Barbora Kessel; Isti Rodiah; Jördis Jennifer Ott; Berit Lange; Gérard Krause
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

Review 4.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

5.  Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.

Authors:  Claudia Lamarca Vitral; Mônica da Silva-Nunes; Marcelo Alves Pinto; Jaqueline Mendes de Oliveira; Ana Maria Coimbra Gaspar; Rebeca Cristina Costa Pereira; Marcelo Urbano Ferreira
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

6.  First evidence of the Hepatitis E virus in environmental waters in Colombia.

Authors:  Paula A Baez; Maria Camila Lopez; Alejandra Duque-Jaramillo; Dioselina Pelaez; Francisco Molina; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

Review 7.  Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants.

Authors:  Essam M Janahi; Saba F D Parkar; Sakina Mustafa; Zaki M Eisa
Journal:  Medicina (Kaunas)       Date:  2020-04-25       Impact factor: 2.430

8.  Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis.

Authors:  Julio Rendon; Maria Cristina Hoyos; Diana di Filippo; Fabian Cortes-Mancera; Carolina Mantilla; Maria Mercedes Velasquez; Maria Elsy Sepulveda; Juan Carlos Restrepo; Sergio Jaramillo; Maria Patricia Arbelaez; Gonzalo Correa; Maria-Cristina Navas
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

Review 9.  Hepatitis E: Update on Prevention and Control.

Authors:  Juliana Gil Melgaço; Noemi Rovaris Gardinali; Vinicius da Motta de Mello; Mariana Leal; Lia Laura Lewis-Ximenez; Marcelo Alves Pinto
Journal:  Biomed Res Int       Date:  2018-01-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.